Dear Colleagues, This month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution. Traditional approaches to treating acne are largely...
Dear Colleagues, Our May Clinical Considerations take a look at a treatment approach to hidradenitis suppurativa, the impact of atopic dermatitis on pediatric patients and a way to prevent mycosis fungoides progression. I’m sure many of us struggle to...
Dear Colleagues, In this month’s Clinical Considerations, we look at handling the difficult patient, how to improve our diagnostic skills and the latest psoriasis drug approval. How many times have you encountered a patient that you knew was going to be...
Dear Colleagues, This month we’re looking at new allergy guideline recommendations, discuss whether or not ‘natural’ soap is milder and novel immunomodulators. What do you do with Peanut allergic patients? Especially pediatrics with Atopic Dermatitis. Recently...
Dear Colleagues, In our February Clinical Considerations, we take a look at treatment options for a few common skin disorders. Most cases of Rosacea respond very well to existing topical and oral agents. Newer topical agents are on the horizon to help improve outcomes...
Dear Colleagues, Hope you’re enjoying the new year! This month, we take a look at when to use biologics, advances in pediatric Atopic Dermatitis (AD), and how Trump’s presidency might impact dermatology. What labs do you order for patients prior to starting a biologic...
